Literature DB >> 10571279

Solid-state 13C nuclear magnetic resonance spectroscopic study on amorphous solid complexes of tolbutamide with 2-hydroxypropyl-alpha- and -beta-cyclodextrins.

K Kimura1, F Hirayama, H Arima, K Uekama.   

Abstract

PURPOSE: The objective of the study was to obtain structural information of inclusion complexes of tolbutamide with HP-alpha- and -beta-cyclodextrins in amorphous state.
METHOD: The solid complexes of tolbutamide with HP-alpha- and -beta-CyDs in molar ratios of 1:1 and 1:2 (guest:host) were prepared by the spray-drying method, and their interactions were investigated by solid-state 13C nuclear magnetic resonance (NMR) spectroscopy.
RESULTS: The solid 1:1 and 1:2 tolbutamide/HP-CyD complexes showed halo pattern on the powder X-ray diffractogram and no thermal change in DSC curves, indicating they are in an amorphous state. 13C NMR signals of the butyl moiety were broader than those of the phenyl moiety in the HP-alpha-CyD solid complex, whereas the phenyl moiety showed significantly broader signals than the butyl moiety in the HP-beta-CyD solid complex. As temperature increased, signals of the phenyl carbons became markedly sharper, whereas the butyl carbons only sharpen slightly in the HP-d-CyD complex. In contrast, signals of the butyl carbons became significantly sharper whereas those of phenyl carbons only slightly changed in the HP-beta-CyD complex.
CONCLUSIONS: Solid state 13C NMR spectroscopic studies indicated that the butyl moiety of tolbutamide is predominantly included in the HP-alpha-CyD cavity, whereas the phenyl moiety in the HP-beta-CyD cavity in amorphous complexes.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10571279     DOI: 10.1023/a:1018958116349

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  9 in total

1.  Structural Aspects of Stereodifferentiation in the Solid State.

Authors:  Kazuaki Harata
Journal:  Chem Rev       Date:  1998-07-30       Impact factor: 60.622

2.  The Stability of Cyclodextrin Complexes in Solution.

Authors:  Kenneth A. Connors
Journal:  Chem Rev       Date:  1997-08-05       Impact factor: 60.622

3.  Determination of the composition of delavirdine mesylate polymorph and pseudopolymorph mixtures using 13C CP/MAS NMR.

Authors:  P Gao
Journal:  Pharm Res       Date:  1996-07       Impact factor: 4.200

4.  Binding specificity between small organic solutes in aqueous solution: classification of some solutes into two groups according to binding tendencies.

Authors:  T Higuchi; H Kristiansen
Journal:  J Pharm Sci       Date:  1970-11       Impact factor: 3.534

Review 5.  Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization.

Authors:  T Loftsson; M E Brewster
Journal:  J Pharm Sci       Date:  1996-10       Impact factor: 3.534

Review 6.  Solid-state nuclear magnetic resonance spectroscopy: theory and pharmaceutical applications.

Authors:  D E Bugay
Journal:  Pharm Res       Date:  1993-03       Impact factor: 4.200

7.  A pharmacokinetic analysis program (multi) for microcomputer.

Authors:  K Yamaoka; Y Tanigawara; T Nakagawa; T Uno
Journal:  J Pharmacobiodyn       Date:  1981-11

8.  Characterization of tolbutamide polymorphs (Burger's forms II and IV) and polymorphic transition behavior.

Authors:  K Kimura; F Hirayama; K Uekama
Journal:  J Pharm Sci       Date:  1999-04       Impact factor: 3.534

9.  Amorphous water-soluble derivatives of cyclodextrins: nontoxic dissolution enhancing excipients.

Authors:  J Pitha; J Pitha
Journal:  J Pharm Sci       Date:  1985-09       Impact factor: 3.534

  9 in total
  2 in total

1.  Deformation behaviors of tolbutamide, hydroxypropyl-beta-cyclodextrin, and their dispersions.

Authors:  E Suihko; A Poso; O Korhonen; J Gynther; J Ketolainen; P Paronen
Journal:  Pharm Res       Date:  2000-08       Impact factor: 4.200

2.  Improvement of dissolution behavior for poorly water-soluble drug by application of cyclodextrin in extrusion process: comparison between melt extrusion and wet extrusion.

Authors:  Hideki Yano; Peter Kleinebudde
Journal:  AAPS PharmSciTech       Date:  2010-05-22       Impact factor: 3.246

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.